Logo image of BN.CA

BROOKFIELD CORP (BN.CA) Stock Fundamental Analysis

TSX:BN - Toronto Stock Exchange - CA11271J1075 - Common Stock - Currency: CAD

83.79  -2.6 (-3.01%)

Fundamental Rating

3

Taking everything into account, BN scores 3 out of 10 in our fundamental rating. BN was compared to 83 industry peers in the Capital Markets industry. There are concerns on the financial health of BN while its profitability can be described as average. BN has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year BN was profitable.
BN had a positive operating cash flow in the past year.
Of the past 5 years BN 4 years were profitable.
In the past 5 years BN always reported a positive cash flow from operatings.
BN.CA Yearly Net Income VS EBIT VS OCF VS FCFBN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10B -10B 20B

1.2 Ratios

With a Return On Assets value of 0.15%, BN is not doing good in the industry: 68.92% of the companies in the same industry are doing better.
BN has a Return On Equity of 1.59%. This is in the lower half of the industry: BN underperforms 67.57% of its industry peers.
With a Return On Invested Capital value of 4.03%, BN perfoms like the industry average, outperforming 40.54% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for BN is significantly below the industry average of 9.07%.
The last Return On Invested Capital (4.03%) for BN is above the 3 year average (3.94%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.15%
ROE 1.59%
ROIC 4.03%
ROA(3y)0.54%
ROA(5y)0.47%
ROE(3y)4.9%
ROE(5y)4.3%
ROIC(3y)3.94%
ROIC(5y)3.62%
BN.CA Yearly ROA, ROE, ROICBN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2 4 6 8 10

1.3 Margins

BN's Profit Margin of 0.81% is on the low side compared to the rest of the industry. BN is outperformed by 66.22% of its industry peers.
In the last couple of years the Profit Margin of BN has declined.
BN's Operating Margin of 24.52% is in line compared to the rest of the industry. BN outperforms 47.30% of its industry peers.
In the last couple of years the Operating Margin of BN has grown nicely.
Looking at the Gross Margin, with a value of 18.62%, BN is doing worse than 67.57% of the companies in the same industry.
BN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 24.52%
PM (TTM) 0.81%
GM 18.62%
OM growth 3Y10.13%
OM growth 5Y6.12%
PM growth 3YN/A
PM growth 5Y-30.16%
GM growth 3Y1.18%
GM growth 5Y6.07%
BN.CA Yearly Profit, Operating, Gross MarginsBN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30 40

1

2. Health

2.1 Basic Checks

BN has less shares outstanding than it did 1 year ago.
BN has more shares outstanding than it did 5 years ago.
The debt/assets ratio for BN has been reduced compared to a year ago.
BN.CA Yearly Shares OutstandingBN.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B
BN.CA Yearly Total Debt VS Total AssetsBN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100B 200B 300B 400B

2.2 Solvency

Based on the Altman-Z score of 0.48, we must say that BN is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.48, BN is in line with its industry, outperforming 50.00% of the companies in the same industry.
BN has a Debt/Equity ratio of 5.26. This is a high value indicating a heavy dependency on external financing.
BN has a Debt to Equity ratio of 5.26. This is amonst the worse of the industry: BN underperforms 93.24% of its industry peers.
Industry RankSector Rank
Debt/Equity 5.26
Debt/FCF N/A
Altman-Z 0.48
ROIC/WACCN/A
WACCN/A
BN.CA Yearly LT Debt VS Equity VS FCFBN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50B 100B 150B

2.3 Liquidity

A Current Ratio of 0.84 indicates that BN may have some problems paying its short term obligations.
BN's Current ratio of 0.84 is on the low side compared to the rest of the industry. BN is outperformed by 75.68% of its industry peers.
BN has a Quick Ratio of 0.84. This is a bad value and indicates that BN is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.66, BN is not doing good in the industry: 78.38% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.84
Quick Ratio 0.66
BN.CA Yearly Current Assets VS Current LiabilitesBN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 20B 40B 60B 80B 100B

4

3. Growth

3.1 Past

BN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 92.39%, which is quite impressive.
Measured over the past 5 years, BN shows a small growth in Earnings Per Share. The EPS has been growing by 5.73% on average per year.
BN shows a decrease in Revenue. In the last year, the revenue decreased by -4.73%.
Measured over the past years, BN shows a quite strong growth in Revenue. The Revenue has been growing by 11.06% on average per year.
EPS 1Y (TTM)92.39%
EPS 3YN/A
EPS 5Y5.73%
EPS Q2Q%15.07%
Revenue 1Y (TTM)-4.73%
Revenue growth 3Y15.19%
Revenue growth 5Y11.06%
Sales Q2Q%-15.62%

3.2 Future

Based on estimates for the next years, BN will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.50% on average per year.
Based on estimates for the next years, BN will show a very negative growth in Revenue. The Revenue will decrease by -38.48% on average per year.
EPS Next Y30.79%
EPS Next 2Y15.61%
EPS Next 3Y17.5%
EPS Next 5YN/A
Revenue Next Year-83.18%
Revenue Next 2Y-55.75%
Revenue Next 3Y-38.48%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BN.CA Yearly Revenue VS EstimatesBN.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20B 40B 60B 80B
BN.CA Yearly EPS VS EstimatesBN.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 1 2 3 4

4

4. Valuation

4.1 Price/Earnings Ratio

BN is valuated correctly with a Price/Earnings ratio of 15.35.
Compared to the rest of the industry, the Price/Earnings ratio of BN is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 28.47. BN is valued slightly cheaper when compared to this.
BN is valuated correctly with a Price/Forward Earnings ratio of 14.36.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BN indicates a somewhat cheap valuation: BN is cheaper than 60.81% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of BN to the average of the S&P500 Index (92.74), we can say BN is valued rather cheaply.
Industry RankSector Rank
PE 15.35
Fwd PE 14.36
BN.CA Price Earnings VS Forward Price EarningsBN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

BN's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.32
BN.CA Per share dataBN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BN's earnings are expected to grow with 17.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.5
PEG (5Y)2.68
EPS Next 2Y15.61%
EPS Next 3Y17.5%

2

5. Dividend

5.1 Amount

BN has a yearly dividend return of 0.48%, which is pretty low.
Compared to an average industry Dividend Yield of 3.26, BN pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.28, BN's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.48%

5.2 History

The dividend of BN decreases each year by -5.12%.
BN has paid a dividend for at least 10 years, which is a reliable track record.
BN has decreased its dividend recently.
Dividend Growth(5Y)-5.12%
Div Incr Years1
Div Non Decr Years1
BN.CA Yearly Dividends per shareBN.CA Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

BN pays out 87.94% of its income as dividend. This is not a sustainable payout ratio.
DP87.94%
EPS Next 2Y15.61%
EPS Next 3Y17.5%
BN.CA Yearly Income VS Free CF VS DividendBN.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -5B -10B
BN.CA Dividend Payout.BN.CA Dividend Payout, showing the Payout Ratio.BN.CA Dividend Payout.PayoutRetained Earnings

BROOKFIELD CORP

TSX:BN (2/4/2025, 7:00:00 PM)

83.79

-2.6 (-3.01%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)11-14 2024-11-14/bmo
Earnings (Next)02-13 2025-02-13/amc
Inst Owners64.33%
Inst Owner ChangeN/A
Ins Owners10.96%
Ins Owner ChangeN/A
Market Cap138.02B
Analysts77.78
Price Target95.79 (14.32%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.48%
Yearly Dividend0.39
Dividend Growth(5Y)-5.12%
DP87.94%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)34.18%
Min EPS beat(2)-0.3%
Max EPS beat(2)68.65%
EPS beat(4)3
Avg EPS beat(4)20.85%
Min EPS beat(4)-0.3%
Max EPS beat(4)68.65%
EPS beat(8)6
Avg EPS beat(8)-3.67%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)1592.59%
Min Revenue beat(2)1473.07%
Max Revenue beat(2)1712.11%
Revenue beat(4)4
Avg Revenue beat(4)798.76%
Min Revenue beat(4)0.84%
Max Revenue beat(4)1712.11%
Revenue beat(8)8
Avg Revenue beat(8)413.33%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.74%
PT rev (3m)23.22%
EPS NQ rev (1m)-0.28%
EPS NQ rev (3m)-3.16%
EPS NY rev (1m)0%
EPS NY rev (3m)5.56%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.87%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.68%
Valuation
Industry RankSector Rank
PE 15.35
Fwd PE 14.36
P/S 1.05
P/FCF N/A
P/OCF 16.53
P/B 2.06
P/tB N/A
EV/EBITDA 10.32
EPS(TTM)5.46
EY6.52%
EPS(NY)5.84
Fwd EY6.97%
FCF(TTM)-12.24
FCFYN/A
OCF(TTM)5.07
OCFY6.05%
SpS79.7
BVpS40.66
TBVpS-22.54
PEG (NY)0.5
PEG (5Y)2.68
Profitability
Industry RankSector Rank
ROA 0.15%
ROE 1.59%
ROCE 5%
ROIC 4.03%
ROICexc 4.14%
ROICexgc 4.97%
OM 24.52%
PM (TTM) 0.81%
GM 18.62%
FCFM N/A
ROA(3y)0.54%
ROA(5y)0.47%
ROE(3y)4.9%
ROE(5y)4.3%
ROIC(3y)3.94%
ROIC(5y)3.62%
ROICexc(3y)4.09%
ROICexc(5y)3.75%
ROICexgc(3y)5.05%
ROICexgc(5y)4.55%
ROCE(3y)4.88%
ROCE(5y)4.48%
ROICexcg growth 3Y16.62%
ROICexcg growth 5Y7.18%
ROICexc growth 3Y14.15%
ROICexc growth 5Y5.45%
OM growth 3Y10.13%
OM growth 5Y6.12%
PM growth 3YN/A
PM growth 5Y-30.16%
GM growth 3Y1.18%
GM growth 5Y6.07%
F-Score6
Asset Turnover0.18
Health
Industry RankSector Rank
Debt/Equity 5.26
Debt/FCF N/A
Debt/EBITDA 7.62
Cap/Depr 203.03%
Cap/Sales 21.72%
Interest Coverage 250
Cash Conversion 18.06%
Profit Quality N/A
Current Ratio 0.84
Quick Ratio 0.66
Altman-Z 0.48
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)227.2%
Cap/Depr(5y)208.74%
Cap/Sales(3y)19.73%
Cap/Sales(5y)17.68%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)92.39%
EPS 3YN/A
EPS 5Y5.73%
EPS Q2Q%15.07%
EPS Next Y30.79%
EPS Next 2Y15.61%
EPS Next 3Y17.5%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.73%
Revenue growth 3Y15.19%
Revenue growth 5Y11.06%
Sales Q2Q%-15.62%
Revenue Next Year-83.18%
Revenue Next 2Y-55.75%
Revenue Next 3Y-38.48%
Revenue Next 5YN/A
EBIT growth 1Y25.89%
EBIT growth 3Y26.86%
EBIT growth 5Y17.86%
EBIT Next Year754.34%
EBIT Next 3Y61.94%
EBIT Next 5YN/A
FCF growth 1Y-32.69%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-28.11%
OCF growth 3Y-8.27%
OCF growth 5Y4.59%